Ultram er and Nausea and vomiting - a phase IV clinical study of FDA data

Summary:

Nausea and vomiting is reported as a side effect among people who take Ultram er (tramadol hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Xanax, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Nausea and vomiting when taking Ultram er. It is created by eHealthMe based on reports of 956 people who have side effects when taking Ultram er from the FDA, and is updated regularly.

What is Ultram er?

Ultram er has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 1,387 Ultram er users. Check the latest studies of Ultram er.

What is Nausea and vomiting?

Nausea and vomiting is found to be associated with 3,705 drugs and 5,745 conditions by eHealthMe. Check the latest studies of Nausea and vomiting.

On Jul, 15, 2026

956 people reported to have side effects when taking Ultram er.
Among them, 47 people (4.92%) have Nausea and vomiting.

Could Ultram er cause Nausea and vomiting?

Among these 47 people:

How long have people been on Ultram er when they have Nausea and vomiting? *

What is the gender of people who have Nausea and vomiting when taking Ultram er? *

female: 86.05 %
male: 13.95 %

What is the age of people who have Nausea and vomiting when taking Ultram er? *

What are other drugs people take besides Ultram er? *

What are other side effects people have besides Nausea and vomiting? *

Nausea (feeling of having an urge to vomit): 21 people, 44.68%
Dizziness: 20 people, 42.55%
Headache (pain in head): 14 people, 29.79%
Rashes (redness): 11 people, 23.40%
Diarrhea: 10 people, 21.28%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 17.02%
Weakness: 8 people, 17.02%
Fatigue (feeling of tiredness): 8 people, 17.02%
Drug Hypersensitivity: 8 people, 17.02%
Loss Of Consciousness: 7 people, 14.89%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 6.38%
Dizziness: 3 people, 6.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.38%
Breakthrough Pain: 2 people, 4.26%
Joint Pain: 2 people, 4.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 4.26%
Hypersensitivity: 2 people, 4.26%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 4.26%
Quit Smoking: 2 people, 4.26%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram er and have Nausea and vomiting?

- Check whether Nausea and vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultram er:

Ultram er (1,387 reports)

Browse all side effects of Ultram er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea and vomiting:

Nausea and vomiting (3,705 drugs)

Browse all the conditions that are associated with Nausea and vomiting:

Nausea and vomiting (5,745 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram er) and Ultram er (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.